Red Flag 1: Guaranteed Results and Cure Language
If you have prediabetes or type 2 diabetes, or you are researching for a family member, you have probably seen the pattern: a polished landing page, a smiling testimonial, and a headline promising a specific A1C drop, a set number of pounds by a set date, or even a "reversal" of your condition. This is the first red flag. No program controls everything that shapes your numbers — medication, diet, activity, sleep, and medical history all matter — so a promise that the same result will happen for every member resembles an impossible-to-fulfill promise, the category that compliance guidance treats as a single egregious policy violation. Vague claims such as "amazing results" are also suspect when the promised specifics never appear, a pattern guidance treats as a normal-level violation. The answer you want to hear is: "We can show our program-level results, and we cannot guarantee your individual outcome." A fixed number is marketing, not evidence.
Red Flag 2: "Free" Offers and Cash-Style Urgency
"Free supplies," "no cost to start," "cash back," "only five spots left" — urgency is a pressure tactic, not a benefit. Compliance guidance documents free and cash-style offers, along with unreasonably cheap offers, as concrete promises that can be impossible to fulfill; in that framework, one egregious policy violation counts as a strike. The countdown timer exists to make you commit before you verify anything. Restricted-content rules add another layer: content that facilitates the online sale of prescription drugs or promotes unapproved drugs and supplements may receive fewer or no ads from certain sources, so a page pushing a supplement-only "cure" deserves extra scrutiny. If an offer seems cheaper than a doctor visit, ask what is not included. Before you enter payment details, ask what "free" actually means: what you must buy, what happens when the trial ends, what the full cost is in writing, and who decides whether you qualify.
Red Flag 3: Vague Credentials and Unverifiable Affiliations
"Accredited," "doctor-approved," "trusted by leading hospitals" — without a named organization, these phrases prove nothing. Publisher standards prohibit misleading statements that misrepresent the purpose or content itself, and prohibit falsely implying affiliation with or endorsement by other organizations. A logo pasted on a page establishes no real relationship; anyone can add a logo. Promised specifics that never appear — such as a page that says "see a list of top doctors near you" and then shows no list — fall into the vague-or-unfulfilled-promise category in compliance guidance. If the program cannot name the credentialing body, give you a credential number and issue date, or let you confirm the affiliation on the organization's own website, treat the claim as unverified. A quick check takes minutes: contact the organization directly or search for the program on its official site. Real affiliations survive that check; vague ones rarely do.
Red Flag 4: Claims That Contradict Your Care Team
The most serious red flag is a program that tells you to stop your medication, ignore your doctor, or replace medical care with a supplement or a meal plan. Publisher content standards prohibit advertising on content that promotes harmful health claims or contradicts authoritative scientific consensus during a major health crisis, and that same boundary is a useful screen for what you read anywhere. Watch for language that frames your care team as the obstacle — phrasing designed to isolate you from the people who know your medical history. Changing or stopping prescribed treatment based on a landing page is a decision no marketing page can assess for you, and content that facilitates the online sale of prescription drugs sits in a restricted category that can receive fewer or no ads from certain sources. A trustworthy program coordinates with your care team; one that discourages the conversation is asking you to trust its page more than your clinician.
Five Questions to Ask Before You Enroll
Before you pay, ask for written answers and keep them. Publisher standards require information to be accurate, complete, and free of misleading omissions; apply the same test to everything a program tells you. These five questions work for any offer.
-
What outcomes can you document? Ask for program-level results with dates, the measurement method, and who collected the data. "Amazing results" is not an answer, and a fixed A1C or weight number without documentation is marketing.
-
Who provides clinical oversight? Ask which professionals review the curriculum, what their qualifications are, and whether they will coordinate with your doctor.
-
What does it actually cost? Request a complete written breakdown: what is included, what happens after any trial period, and the refund policy — before you share payment details.
-
How is my health data used? Ask who stores it, who it is shared with, whether it is sold, and how you can delete it.
-
Can my doctor review the curriculum? A confident program will share its educational materials with your care team and welcome their questions.
If a program hesitates on any of these, that hesitation is information. Legitimate offers explain themselves in writing; pressure-based offers rely on speed.
Next Steps and Limits
This article evaluates marketing claims, not specific programs; no named program was reviewed here. Program-specific facts — recognition, coverage, pricing, and outcomes — were not verified in the materials behind this piece and must be confirmed with official sources. Costs, insurance, and program availability vary by state and by individual coverage. Nothing in this article is medical advice: talk to your doctor or a diabetes care and education specialist before changing any part of your treatment. If a program resists that conversation, treat the resistance as the final red flag. Bring the program's written answers to your next appointment and read them with your clinician. The standards referenced here — Google's publisher content policies and compliance guidance — are screening tools for claims, not evaluations of any program's quality or safety.
研究の知恵